EDOX-LB Capsules

A multifaceted antibiotic for acne vulgaris, rosacea and SSTI.

Antibiotic

Anti-Biotic Division

A Multifaceted Antibiotic

EDOX-LB (Doxycycline combined with Lactic Acid Bacillus) is an oral broad-spectrum tetracycline antibiotic paired with a probiotic spore-former to prevent antibiotic-associated diarrhea and maintain intestinal flora during treatment.

Composition: Doxycycline 100 mg + Lactic Acid Bacillus 5 Billion Spores
Class: Antibiotic
Form: Capsules
Pack: 10 × 10 capsules
Division: Anti-Biotic

Specialties

DermatologyVenereologyUrology / Sexual HealthPulmonology & Respiratory MedicineInfectious Diseases & Vector-Borne IllnessesOphthalmology & ENTGastroenterologyGeneral Medicine

Key Benefits

Targeted Therapy. Multiple Benefits.

Acne VulgarisSignificantly decreases clinical signs and symptoms of acne vulgaris.
RosaceaDesigned to provide significant results in rosacea.
TolerabilitySafe and well tolerated compared with first-generation tetracyclines.
Comedone ReductionGreater reduction in the number of comedones.

Pack Specifications

Pack & product details

As per the approved packaging artwork.

Product name: EDOX-LB — Doxycycline and Lactic Acid Bacillus Capsules
Composition: Each hard gelatin capsule contains: Doxycycline Hydrochloride IP eq. to Doxycycline 100 mg, Lactic Acid Bacillus 5 billion spores, Excipients q.s. Approved colour used in empty capsule shell.
Packing type: 10 × 10 Aluminium Strip

Clinical Applications

Cross-specialty clinical applications

How it is used across medical specialties.

Dermatology

Acne Vulgaris: Moderate-to-severe inflammatory acne (systemic control of Cutibacterium acnes).
Rosacea: Papulopustular rosacea (anti-inflammatory and antimicrobial effect).
Hidradenitis Suppurativa & Bacterial Folliculitis: Long-term low-dose/standard immunomodulation and infection control.

Venereology & Urology / Sexual Health

Non-Gonococcal Urethritis (NGU) & Cervicitis: Primary treatment for Chlamydia trachomatis and Mycoplasma genitalium.
Pelvic Inflammatory Disease (PID): Outpatient empirical regimens (combined with metronidazole/ceftriaxone).
Syphilis & Lymphogranuloma Venereum: Alternative regimen in penicillin-allergic patients.
Chronic Bacterial Prostatitis: Deep tissue penetration for susceptible organisms.

Pulmonology & Respiratory Medicine

Community-Acquired Pneumonia (CAP): Atypical coverage (Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella).
Acute Exacerbation of Chronic Bronchitis / COPD: Empirical coverage for upper and lower respiratory pathogens.

Infectious Diseases & Vector-Borne Illnesses

Rickettsial Infections: Scrub typhus, Rocky Mountain spotted fever, and epidemic typhus.
Spirochetal & Zoonotic Infections: Leptospirosis (treatment and prophylaxis), Lyme disease (Borrelia burgdorferi), and Brucellosis (in combination with rifampin/aminoglycosides).
Malaria: Prophylaxis and treatment (in combination with artemisinin derivatives/quinine) for Plasmodium falciparum.

Ophthalmology & ENT

Ocular Rosacea & Meibomian Gland Dysfunction (MGD): Systemic anti-inflammatory control to improve tear film quality.
Trachoma: Secondary management of ocular Chlamydia trachomatis.
Acute Sinusitis: Alternative choice for β-lactam-allergic patients.

Gastroenterology & General Medicine

Intestinal Amebiasis & Cholera: Adjunctive treatment for severe watery diarrhea or parasitic infections.
Periodontitis (Dental/Oral Surgery): Adjunctive systemic therapy for progressive adult periodontitis.

Schedule H Prescription Drug — CautionNot to be sold by retail without the prescription of a Registered Medical Practitioner.

Other Divisions